Browse the latest research summaries in the field of regenerative medicine for spinal cord injury patients and caregivers.
Showing 541-550 of 2,298 results
Neural Regeneration Research, 2024 • November 8, 2023
Combining neural progenitor cell (NPC) transplantation with rehabilitation training enhances functional recovery after cervical spinal cord injury (SCI) by promoting corticospinal tract (CST) axon reg...
KEY FINDING: NPC transplants are a potential pro-regenerative therapy that elicits a robust host axonal regeneration and extensive axonal extension from transplant-derived neurons.
Surgical Neurology International, 2023 • December 13, 2023
This study demonstrates the potential of Neuro-PEG, a PEG-chitosan conjugate, to induce sensorimotor recovery in swine after complete spinal cord transection. The experimental group treated with Neuro...
KEY FINDING: Neuro-PEG treatment led to the recovery of motor function in pigs after complete spinal cord transection.
eNeuro, 2024 • February 1, 2024
This study investigates a novel combined therapy for chronic spinal cord injury (SCI) in rats, involving neural stem/progenitor cell transplantation, rehabilitation, and a semaphorin 3A inhibitor (Sem...
KEY FINDING: The combined therapy significantly improved host-derived neuronal and oligodendrocyte differentiation at the SCI epicenter.
Spine Surg Relat Res, 2024 • January 1, 2024
This review discusses the potential of regenerative medicine, particularly iPSC-derived NPC transplantation, for treating SCI. It highlights the mechanisms underlying functional recovery, including ne...
KEY FINDING: Transplanted NPCs secrete neurotrophic factors to attenuate secondary damage and differentiate into neurons that establish synaptic connections with host axons, contributing to functional recovery after SCI.
CNS Neurosci Ther, 2024 • January 1, 2024
This research investigates the role of Serum Response Factor (SRF) in promoting axonal regeneration following spinal cord injury (SCI) in rats. The study demonstrates that SRF expression increases aft...
KEY FINDING: SRF expression increases after spinal cord injury (SCI) and promotes axonal regeneration.
Frontiers in Molecular Neuroscience, 2024 • February 1, 2024
This study investigates the therapeutic potential of menstrual blood-derived stem cells (MenSCs) in treating spinal cord injury (SCI) in rats by analyzing transcriptome profiles. The research identifi...
KEY FINDING: MenSCs treatment improves motor function recovery and reduces spinal cord lesion volume in SCI rats.
Nature Communications, 2024 • March 6, 2024
This Phase I clinical trial demonstrates the safety of intrathecal administration of culture-expanded 1 × 108 cells of autologous AD-MSCs for patients with traumatic SCI. Stem cells were successfully ...
KEY FINDING: The study demonstrated that AD-MSC harvesting and administration were well-tolerated in patients with traumatic SCI.
Frontiers in Neurology, 2024 • April 2, 2024
This study investigates global research trends and hotspots in AI applications for spinal cord neural injury and restoration using bibliometric and visualization analysis. Key findings highlight the U...
KEY FINDING: The United States leads in the number of published articles on AI research in spinal cord neural injury and restoration.
Nature Communications, 2024 • April 1, 2024
This article is an author's correction to a previously published study on intrathecal delivery of adipose-derived mesenchymal stem cells (AD-MSCs) in traumatic spinal cord injury. The correction invol...
KEY FINDING: The average duration between injury and AD-MSC injection was corrected to 12 months (range of 7–22).
Frontiers in Cellular Neuroscience, 2024 • May 22, 2024
This study compared the effects of BMP4 alone and a bFGF/BMP4 combination on neural stem cells (NSCs) in vitro, using RNA sequencing to analyze transcriptome profiles and immunofluorescence to validat...
KEY FINDING: Both BMP4 alone and bFGF/BMP4 combination induce a quiescent state in neural stem cells (qNSCs), but they result in different levels of quiescence.